Oncopharmpod
Belzutifan and Recent Updates
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:16:30
- More information
Informações:
Synopsis
Belzutifan, the 1st hypoxia-inducible factor (HIF) inhibitor is FDA-approved. Plus, expanded indication approvals for nivolumab, dostarlimab, lenvatinib/pembrolizumab, & Ivosidenib. Finally, my Top 5 Rolling Stones Songs (14:30).
